Search Results

PFK-015 5 mg  | 99.70%

TargetMol

PFK-015 (PFK15) is an effective inhibitor of PFKFB3 (IC50: 110 nM) and inhibits PFKFB3 activity in Y cells (IC50: 20 nM).

More Information Supplier Page

Latanoprost 10 mg  | Purity Not Available

TargetMol

Latanoprost is a prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect.

More Information Supplier Page

Latanoprost 50 mg  | Purity Not Available

TargetMol

Latanoprost is a prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect.

More Information Supplier Page

Latanoprost 5 mg  | Purity Not Available

TargetMol

Latanoprost is a prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect.

More Information Supplier Page

Tolmetin 100 mg  | Purity Not Available

TargetMol

Tolmetin is a Nonsteroidal Anti-inflammatory Drug. The mechanism of action of tolmetin is as a Cyclooxygenase Inhibitor. The chemical classification of tolmetin is Nonsteroidal Anti-inflammatory Compounds.

More Information Supplier Page

Dolutegravir sodium 5 mg  | 99.74%

TargetMol

Dolutegravir sodium salt(DTG; GSK1349572) is an HIV integrase inhibitor(IC50: 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.

More Information Supplier Page

Dolutegravir sodium 50 mg  | 99.74%

TargetMol

Dolutegravir sodium salt(DTG; GSK1349572) is an HIV integrase inhibitor(IC50: 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.

More Information Supplier Page

Dolutegravir sodium 2 mg  | 99.74%

TargetMol

Dolutegravir sodium salt(DTG; GSK1349572) is an HIV integrase inhibitor(IC50: 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.

More Information Supplier Page

Dolutegravir sodium 25 mg  | 99.74%

TargetMol

Dolutegravir sodium salt(DTG; GSK1349572) is an HIV integrase inhibitor(IC50: 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.

More Information Supplier Page

Darunavir 50 mg  | Purity Not Available

TargetMol

Darunavir is an HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when used alone, it is administered in combination with other ANTI-HIV AGENTS.

More Information Supplier Page